Literature DB >> 28710277

Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization.

Andrew S Murray1,2,3,4, Fausto A Varela1,5, Thomas E Hyland1, Andrew J Schoenbeck1, Jordan M White1,2,3,4, Lauren M Tanabe1, Sokol V Todi1,6, Karin List7,2,4.   

Abstract

TMPRSS13 is a member of the type II transmembrane serine protease (TTSP) family. Although various TTSPs have been characterized in detail biochemically and functionally, the basic properties of TMPRSS13 remain unclear. Here, we investigate the activation, inhibition, post-translational modification, and localization of TMPRSS13. We show that TMPRSS13 is a glycosylated, active protease and that its own proteolytic activity mediates zymogen cleavage. Full-length, active TMPRSS13 exhibits impaired cell-surface expression in the absence of the cognate Kunitz-type serine protease inhibitors, hepatocyte growth factor activator inhibitor (HAI)-1 or HAI-2. Concomitant presence of TMPRSS13 with either HAI-1 or -2 mediates phosphorylation of residues in the intracellular domain of the protease, and it coincides with efficient transport of the protease to the cell surface and its subsequent shedding. Cell-surface labeling experiments indicate that the dominant form of TMPRSS13 on the cell surface is phosphorylated, whereas intracellular TMPRSS13 is predominantly non-phosphorylated. These data provide novel insight into the cellular properties of TMPRSS13 and highlight phosphorylation of TMPRSS13 as a novel post-translational modification of this TTSP family member and potentially other members of this family of proteases.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  HAI-1; HAI-2; TMPRSS13; TTSP; cell-surface protein; enzyme mechanism; phosphorylation; protease inhibitor; serine protease; type II transmembrane serine protease

Mesh:

Substances:

Year:  2017        PMID: 28710277      PMCID: PMC5592667          DOI: 10.1074/jbc.M117.775999

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

2.  TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.

Authors:  Tomio Hashimoto; Minoru Kato; Takeshi Shimomura; Naomi Kitamura
Journal:  FEBS J       Date:  2010-10-26       Impact factor: 5.542

3.  Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.

Authors:  Roman Szabo; John P Hobson; Karin List; Alfredo Molinolo; Chen-Yong Lin; Thomas H Bugge
Journal:  J Biol Chem       Date:  2008-08-19       Impact factor: 5.157

4.  Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch.

Authors:  Alaji Bah; Robert M Vernon; Zeba Siddiqui; Mickaël Krzeminski; Ranjith Muhandiram; Charlie Zhao; Nahum Sonenberg; Lewis E Kay; Julie D Forman-Kay
Journal:  Nature       Date:  2014-12-22       Impact factor: 49.962

5.  Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

Authors:  Daniel Kirchhofer; Mark Peek; Michael T Lipari; Karen Billeci; Bin Fan; Paul Moran
Journal:  FEBS Lett       Date:  2005-03-28       Impact factor: 4.124

6.  Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation.

Authors:  Sarah Netzel-Arnett; Brooke M Currie; Roman Szabo; Chen-Yong Lin; Li-Mei Chen; Karl X Chai; Toni M Antalis; Thomas H Bugge; Karin List
Journal:  J Biol Chem       Date:  2006-09-15       Impact factor: 5.157

7.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

8.  Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits.

Authors:  A D Wegener; L R Jones
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

9.  TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition.

Authors:  Daniel H Madsen; Roman Szabo; Alfredo A Molinolo; Thomas H Bugge
Journal:  Biochem J       Date:  2014-08-01       Impact factor: 3.857

10.  N-Glycan Branching Affects the Subcellular Distribution of and Inhibition of Matriptase by HAI-2/Placental Bikunin.

Authors:  Ying-Jung J Lai; Hsiang-Hua D Chang; Hongyu Lai; Yuan Xu; Frank Shiao; Nanxi Huang; Linpei Li; Ming-Shyue Lee; Michael D Johnson; Jehng-Kang Wang; Chen-Yong Lin
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

View more
  9 in total

1.  The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.

Authors:  Andrew S Murray; Thomas E Hyland; Kimberley E Sala-Hamrick; Jacob R Mackinder; Carly E Martin; Lauren M Tanabe; Fausto A Varela; Karin List
Journal:  Oncogene       Date:  2020-08-31       Impact factor: 9.867

Review 2.  Cell surface-anchored serine proteases in cancer progression and metastasis.

Authors:  Carly E Martin; Karin List
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

3.  The Kunitz-type serine protease inhibitor Spint2 is required for cellular cohesion, coordinated cell migration and cell survival during zebrafish hatching gland development.

Authors:  Julia Hatzold; Heike Wessendorf; Hans-Martin Pogoda; Wilhelm Bloch; Matthias Hammerschmidt
Journal:  Dev Biol       Date:  2021-04-04       Impact factor: 3.148

4.  Establishment of stable Vero cell lines expressing TMPRSS2 and MSPL: A useful tool for propagating porcine epidemic diarrhea virus in the absence of exogenous trypsin.

Authors:  Xiaona Wang; Xinyuan Qiao; Ling Sui; Haiyuan Zhao; Fengsai Li; Yan-Dong Tang; Wen Shi; Yuyao Guo; Yanping Jiang; Li Wang; Han Zhou; Lijie Tang; Yigang Xu; Yijing Li
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

5.  The Cytotoxicity of RNase-Derived Peptides.

Authors:  Vera Ulyanova; Elena Dudkina; Alsu Nadyrova; Vladimir Kalashnikov; Yulia Surchenko; Olga Ilinskaya
Journal:  Biomolecules       Date:  2020-12-26

6.  Identification of the co-differentially expressed hub genes involved in the endogenous protective mechanism against ventilator-induced diaphragm dysfunction.

Authors:  Dong Zhang; Wenyan Hao; Qi Niu; Dongdong Xu; Xuejiao Duan
Journal:  Skelet Muscle       Date:  2022-09-09       Impact factor: 5.063

7.  IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike.

Authors:  Jérôme Gatineau; Charlotte Nidercorne; Aurélie Dupont; Marie-Line Puiffe; José L Cohen; Valérie Molinier-Frenkel; Florence Niedergang; Flavia Castellano
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

8.  Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.

Authors:  Annelies Stevaert; Ria Van Berwaer; Cato Mestdagh; Julie Vandeput; Els Vanstreels; Valerie Raeymaekers; Manon Laporte; Lieve Naesens
Journal:  mBio       Date:  2022-08-01       Impact factor: 7.786

9.  TMPRSS13 promotes cell survival, invasion, and resistance to drug-induced apoptosis in colorectal cancer.

Authors:  Fausto A Varela; Victoria L Foust; Thomas E Hyland; Kimberley E Sala-Hamrick; Jacob R Mackinder; Carly E Martin; Andrew S Murray; Sokol V Todi; Karin List
Journal:  Sci Rep       Date:  2020-08-17       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.